The company manufactures and exports 100% cotton infant apparel and distributes aluminum and steel roofing sheets and accessories, primarily serving international garment buyers and the domestic Kerala construction market.
The company operates in highly fragmented and commoditized industries with no evidence of pricing power, as reflected by negative average net margins and low ROCE. While it leverages the 'Anna Group' legacy, the financial results contradict any meaningful brand or scale advantage.
Capital has been deployed into low-return business lines and related-party transactions. Recent plans to raise 500 million INR via a rights issue to repay debt suggests the business is not self-sustaining at its current scale.
The business collapsed because it was never a self-sustaining enterprise, but rather a captive entity for the Anna Kitex Group. Despite rapid revenue growth, the company could not generate a single rupee of real profit, eventually drowning under interest obligations that its negative margins couldn't support. The 500 million INR rights issue served only as a temporary bandage for debt repayment rather than growth, and when the related-party support from Kitex entities shifted or tightened, the lack of independent pricing power and the abysmal 5.4% ROCE led to a total wipeout of minority shareholder value.
RichFakir rates Scoobee Day Garments India Ltd's business quality as poor — 34/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Scoobee Day Garments India Ltd is trading about 74% above our estimate of fair value; we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Scoobee Day Garments India Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Scoobee Day Garments India Ltd's fair value is about ₹33 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →